BE846837A - Composes et compositions a activite antiallergique et anti-anaphylactique, - Google Patents

Composes et compositions a activite antiallergique et anti-anaphylactique,

Info

Publication number
BE846837A
BE846837A BE171148A BE171148A BE846837A BE 846837 A BE846837 A BE 846837A BE 171148 A BE171148 A BE 171148A BE 171148 A BE171148 A BE 171148A BE 846837 A BE846837 A BE 846837A
Authority
BE
Belgium
Prior art keywords
antiallergic
compositions
compounds
antianaphylactic
activity
Prior art date
Application number
BE171148A
Other languages
English (en)
French (fr)
Inventor
L A Svenseon
L M Sorenby
K I L Wetterlin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE846837A publication Critical patent/BE846837A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/04Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reaction of ammonia or amines with olefin oxides or halohydrins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • C07C45/71Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/301,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C07D265/321,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
BE171148A 1975-10-01 1976-10-01 Composes et compositions a activite antiallergique et anti-anaphylactique, BE846837A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7510988A SE7510988L (sv) 1975-10-01 1975-10-01 Nya farmaceutiskt aktiva foreningar

Publications (1)

Publication Number Publication Date
BE846837A true BE846837A (fr) 1977-04-01

Family

ID=20325688

Family Applications (1)

Application Number Title Priority Date Filing Date
BE171148A BE846837A (fr) 1975-10-01 1976-10-01 Composes et compositions a activite antiallergique et anti-anaphylactique,

Country Status (19)

Country Link
JP (1) JPS5242840A (instruction)
AT (1) AT347427B (instruction)
AU (1) AU503212B2 (instruction)
BE (1) BE846837A (instruction)
CS (2) CS199643B2 (instruction)
DD (1) DD126278A5 (instruction)
DE (1) DE2640972A1 (instruction)
DK (1) DK141622B (instruction)
ES (1) ES451979A1 (instruction)
FI (1) FI762660A7 (instruction)
FR (1) FR2326183A1 (instruction)
GB (1) GB1542317A (instruction)
LU (1) LU75916A1 (instruction)
NL (1) NL7610845A (instruction)
NO (1) NO763345L (instruction)
NZ (1) NZ182165A (instruction)
SE (1) SE7510988L (instruction)
SU (2) SU638252A3 (instruction)
ZA (1) ZA765331B (instruction)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0043807B1 (en) 1980-07-09 1984-05-30 Aktiebolaget Draco 1-(dihydroxyphenyl)-2-amino-ethanol derivatives; preparation, compositions and intermediates
EP0103830A3 (de) * 1982-09-22 1985-07-31 Bayer Ag Wachstumsfördernde Phenylethylamin-Derivate
DE69633613T2 (de) * 1995-12-28 2006-02-09 Mitsubishi Pharma Corp. 2-amino-2-(2-(4-octylphenyl)ethyl)propan-1,3-diol enthaltendes Arzneimittel zur topischen Anwendung zur Behandlung von Erkrankungen,die durch eine Störung des Immunsystems hervorgerufen werden
SI2332921T1 (sl) 2003-06-17 2016-06-30 Arena Pharmaceuticals, Inc. 8-kloro-1-metil-2,3,4,5-tetrahidro-1H-3-benzazapin hidroklorid
EP2518053A1 (en) 2006-04-03 2012-10-31 Arena Pharmaceuticals, Inc. Process for the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine
ES2522587T3 (es) 2006-12-05 2014-11-17 Arena Pharmaceuticals, Inc. Procesos para preparar (R)-8-cloro-1-metil-2,3,4,5-tetrahidro-1H-3-benzacepina e intermedios de la misma
RU2361604C1 (ru) * 2007-10-29 2009-07-20 Федеральное агентство по высокотехнологичной медицинской помощи Федеральное государственное учреждение "Уральский научно-исследовательский институт дерматовенерологии и иммунопатологии" (ФГУ УрНИИДВиИ Росмедтехнологий) Способ лечения атопического дерматита
CN102015591B (zh) 2008-03-04 2014-01-29 艾尼纳制药公司 制备与5-ht2c激动剂(r)-8-氯-1-甲基-2,3,4,5-四氢-1h-3-苯并氮杂卓相关的中间体的方法
CN102648170A (zh) 2009-06-18 2012-08-22 艾尼纳制药公司 制备5-ht2c受体激动剂的方法
US9045431B2 (en) 2010-06-02 2015-06-02 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-HT2C receptor agonists
JP2013536859A (ja) 2010-09-01 2013-09-26 アリーナ ファーマシューティカルズ, インコーポレイテッド 5−ht2cアゴニストの非吸湿性塩
MX2013002422A (es) 2010-09-01 2013-05-17 Arena Pharm Inc Sales de lorcaserina con acidos opticamente activos.
JP6272695B2 (ja) 2010-09-01 2018-01-31 エーザイ・アール・アンド・ディー・マネジメント株式会社 体重管理のために有用な5−ht2cアゴニストの改変放出剤形
SG10201506896RA (en) 2010-09-01 2015-10-29 Arena Pharm Inc Administration of lorcaserin to individuals with renal impairment
RU2674670C1 (ru) 2012-10-09 2018-12-12 Арена Фармасьютикалз, Инк. Способ коррекции массы тела

Also Published As

Publication number Publication date
GB1542317A (en) 1979-03-14
ZA765331B (en) 1977-08-31
AU503212B2 (en) 1979-08-30
DK141622B (da) 1980-05-12
ES451979A1 (es) 1978-01-01
SU674669A3 (ru) 1979-07-15
NL7610845A (nl) 1977-04-05
JPS5242840A (en) 1977-04-04
DK439776A (instruction) 1977-04-02
CS199643B2 (en) 1980-07-31
AU1812276A (en) 1978-04-06
SE7510988L (sv) 1977-04-02
DD126278A5 (instruction) 1977-07-06
SU638252A3 (ru) 1978-12-15
NO763345L (instruction) 1977-04-04
NZ182165A (en) 1978-07-10
LU75916A1 (instruction) 1978-05-16
AT347427B (de) 1978-12-27
FR2326183A1 (fr) 1977-04-29
DE2640972A1 (de) 1977-04-14
CS199644B2 (en) 1980-07-31
FI762660A7 (instruction) 1977-04-02
ATA682376A (de) 1978-05-15

Similar Documents

Publication Publication Date Title
ZA762285B (en) New phenyl-alkane-carboxylic acid derivatives
AU1934876A (en) Hydroxybenzylmalonic acid derivatives
SE393030B (sv) Hopsettbar leksaksfigur
MC1101A1 (fr) Composition a activite retardee
EG12712A (en) Phenoxy-phenoxypropionic acid derivatives
NZ182908A (en) 2-tertiaryaminoindol-3-ylcarboxylic acid derivatives
NL7606655A (nl) Imidylbenzeendi- en -tricarbonzuurderivaten.
BE846837A (fr) Composes et compositions a activite antiallergique et anti-anaphylactique,
BE847718A (fr) Nouveaux composes a activite anti-fertilite,
MY8100161A (en) Hydroxybenzylmalonic acid derivatives
ZA774737B (en) Novel azolyl-carboxylic acid derivatives and their use as fungicides
AU506250B2 (en) Clavulanic acid derivatives
NL7704174A (nl) Nieuwe m-fenylfenoxypropionzuurderivaten en de bereidingswijze daarvan.
ZA766183B (en) New phenoxyalkylcarboxylic acid derivatives
ZA765531B (en) New phenoxyalkylcarboxylic acid derivatives
GB1554299A (en) Phenylacetic acid derivatives
BE828690A (fr) Composes a activite anti-allergique
FR2293204A1 (fr) 6-methylergolines 8,8-disubstituees et composes apparentes
FR2333497A2 (fr) Composes azotes
BE843416A (fr) Nouveaux composes a activite pesticide
GB1539897A (en) Phenoxypropionic acid derivatives
IE43457L (en) 1-deoxyribofuranuronic acid derivatives
ZA764209B (en) Azanaphthaleneacetic acid derivatives
JPS52111556A (en) Glycylretinic acid derivatives
BE854690A (fr) Composition antiallergique